1. Finding New Approaches to Immunotherapy

    Helen Heslop, M.D., leads a team of scientists being funded through LLS’s Specialized Center of Research Program (SCOR). The project brings together researchers from different institutions to test a half dozen novel approaches to cancer immunotherapy – all of which harness the patient's own immune system to fight the cancer. Heslop, a professor in the Department of Medicine and Pediatrics at Baylor College of Medicine and the director of the Center for Cell and Gene Therapy, pioneered...

    Read More
  2. LLS e-Newsletters

    Let us do the work for you. Receive a monthly email with the latest disease-specific news, research studies, clinical trials and support resources for people living with blood cancer. Sign up here to subscribe to Leukemia Links, Lymphoma Links, Myeloma Links, and eNewsline.

    Read More
  3. Significant Advance for Hodgkin Lymphoma Patients

    The Food & Drug Administration’s accelerated approval of an immunotherapy for patients with Hodgkin lymphoma who have failed other treatments is a positive development for patients who face a very poor prognosis. While Hodgkin lymphoma is now considered one of the most curable forms of cancer – with a more than 86 percent five-year-survival rate overall – those patients who relapse after treatment have a much reduced chance of survival. FDA’s approval of nivolumab (Opdivo®)...

    Read More
  4. Diagnosed with a Blood Cancer? Important Questions You Might Not Think to Ask

    What is my actual diagnosis? Find out your exact diagnosis. Ask your doctor to write down the exact name of your sub-type and take the paper with you. For example, knowing you have “a B-cell lymphoma” isn’t good enough. Follicular and diffuse large B-cell are both B-cell lymphomas but with very different prognoses and treatment plans. Leukemia also has different sub-types. Knowing your specific sub-type helps you understand what disease you are dealing with, how aggressive it is, and wh...

    Read More
  5. What’s new in LLS Community

    We have a new group for Healthcare Professionals! Are you a psychologist, social worker, nurse, physician or other healthcare professional treating patients with blood cancers? Connect with other professionals and receive notices of educational opportunities directly to your feed. To join, visit the Groups tab and then click on Private.

    Read More
  6. Struggling with Weight Gain During Treatment

    Unplanned weight gain is not usually discussed as a side effect of cancer treatment, but when it happens, a patient can experience other possible negative effects. For cancer patients, weight gain is usually not a result of increased muscle, which can be a good thing, but of increased fatty tissue, which may lead to chronic inflammation. Excess body weight is linked to an increased risk for other serious medical conditions such as heart disease, diabetes, high blood pressure and circulatio...

    Read More
  7. A New Meaning to Mother's Day

    By Sarah Mowat We were having lunch with friends recently. The kids all went off in different directions, attempting various perilous toddler style ‘mission impossible’ stunts. My husband, Nick and I have a sweet and shy three year old, Evie, and a wild and wonderful almost 2 year old, Isobel. Whilst observing this nail biting display of toddler theatrics, we discussed the realities of parenting; the beauty, love, worry and exhaustion that intertwine and add a whole new meaning to o...

    Read More
  8. Panelists Discuss the AML Patient Experience

    What is AML? What research is underway? And what resources are available to patients? The Leukemia & Lymphoma Society recently joined up with Patient Power and the MDS Alliance to host an AML Awareness Day and answer those questions. The April 21 webcast was moderated by Carol Preston, host of Patient Power, an online portal offering cancer information for both patients and professionals. Preston is also a chronic lymphocytic leukemia (CLL) survivor. The panelists were Ellen Ritc...

    Read More
  9. Looking Back at Lymphoma (23 Years Later!)

    Life is a journey and I can personally attest to the many obstacles, emotions, milestones and lessons learned that come with it. I found out the hard way that life isn’t fair and there are no guarantees. I am told by many that there is a plan. That plan is to lead by example and love my life, myself and everybody in it. Those that know me will tell you I have a contagious personality in that I am happy, loved and fulfilled. I am no longer affected by what others think of me. My plan is...

    Read More
  10. Bringing the Patient Voice into Drug Development

    Wanting to make sure the patient voice is heard when it comes to the development of new therapies, The Leukemia & Lymphoma Society (LLS) recently brought a delegation to Washington D.C. to share personal experiences with the U.S. Food & Drug Administration (FDA). Plans for a research study to learn what patients and caregivers are looking for in new treatments were also presented. LLS’s Office of Public Policy knows the importance of pushing for new drug development, but you can...

    Read More